Is Quidel (QDEL) stock a buy or sell?
Quidel has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 3 buy ratings, no hold ratings, and no sell ratings. According to analysts' consensus price target of $148.50, Quidel has a forecasted downside of 1.1% from its current price of $150.11.
What are analysts'price targets for Quidel's stock?
3 Wall Street analysts have issued 12-month price objectives for Quidel's stock. Their forecasts range from $80.00 to $219.00. On average, they expect Quidel's share price to reach $148.50 in the next twelve months. This suggests that the stock has a possible downside of 1.1%.
How much money does Quidel make a year?
Quidel has a market capitalization of $6.26 billion and generates $1.66 billion in revenue each year. The company earns $810.29 million in net income (profit) each year or $20.40 on an earnings per share basis. How many employees does Quidel have?
Who is the CEO of Quidel?
47 employees have rated Quidel CEO Doug Bryant on Glassdoor.com. Doug Bryant has an approval rating of 76% among Quidel's employees. Who are some of Quidel's key competitors?
Is Quidel a buy or sell?
The Price to Earnings ratio or P/E is price divided by earnings....Momentum Scorecard. More Info.Zacks RankDefinitionAnnualized Return1Strong Buy24.75%2Buy18.15%3Hold9.70%4Sell5.35%2 more rows
Is Qdel stock a buy?
The consensus among 1 Wall Street analyst covering (NASDAQ: QDEL) stock is to Strong Buy QDEL stock.
What is the target price for Qdel?
Stock Price Target QDELHigh$219.00Median$120.00Low$86.00Average$134.20Current Price$102.08
Should I buy or sell QuidelOrtho stock right now?
3 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for QuidelOrtho in the last twelve months. There are currently 2 buy...
What is QuidelOrtho's stock price forecast for 2022?
3 brokers have issued 12-month price targets for QuidelOrtho's stock. Their forecasts range from $80.00 to $219.00. On average, they expect QuidelO...
How has QuidelOrtho's stock price performed in 2022?
QuidelOrtho's stock was trading at $134.99 on January 1st, 2022. Since then, QDEL stock has decreased by 27.8% and is now trading at $97.49. View...
When is QuidelOrtho's next earnings date?
QuidelOrtho is scheduled to release its next quarterly earnings announcement on Thursday, August 4th 2022. View our earnings forecast for QuidelOr...
How were QuidelOrtho's earnings last quarter?
QuidelOrtho Co. (NASDAQ:QDEL) issued its quarterly earnings results on Wednesday, May, 4th. The company reported $11.53 earnings per share (EPS) fo...
What guidance has QuidelOrtho issued on next quarter's earnings?
QuidelOrtho updated its first quarter 2022 earnings guidance on Thursday, April, 21st. The company provided EPS guidance of for the period. The com...
Who are QuidelOrtho's key executives?
QuidelOrtho's management team includes the following people: Mr. Douglas C. Bryant , Chairman & CEO (Age 64, Pay $1.41M) ( LinkedIn Profile ) Mr...
What is Doug Bryant's approval rating as QuidelOrtho's CEO?
47 employees have rated QuidelOrtho CEO Doug Bryant on Glassdoor.com . Doug Bryant has an approval rating of 76% among QuidelOrtho's employees.
Who are some of QuidelOrtho's key competitors?
Some companies that are related to QuidelOrtho include West Pharmaceutical Services (WST) , Align Technology (ALGN) , Cooper Companies (COO) ,...
About Quidel
Headlines
Quidel Corp. engages in the development, manufacture and market of rapid diagnostic testing solutions. Its portfolio includes rapid immunoassays, cardiac immunoassays, specialized diagnostic solutions and molecular diagnostic solutions.
Why Quidel Was Trouncing the Market on Tuesday
Quidel shares are trading higher after the company reported better-than-expected Q4 adjusted EPS and sales results. - Benzinga
Quidel (QDEL) Q4 Earnings Top Estimates, Margins Decline
On Tuesday, Quidel (NASDAQ: QDEL) was a bright spot in a generally downbeat and gloomy stock market. Shares of the healthcare-diagnostics specialist were up by more than 6% in late afternoon trading, following an extremely bullish new research note from an analyst. The raging bull is Raymond James prognosticator Andrew Cooper.
Why Quidel Stock Is Popping Today
Despite robust revenues from COVID-19 products, Quidel (QDEL) records an overall soft Q4 performance.
Quidel (QDEL) Tops Q4 Earnings and Revenue Estimates
Quidel (NASDAQ: QDEL) stock was popping on Friday with shares jumping 11.3% as of 11:02 a.m. ET. The diagnostics testing company reported fourth-quarter revenue of $636.9 million. Although this reflected a sharp 21.2% year-over-year decline, it still narrowly topped the consensus estimate.
Quidel (QDEL) to Report Q4 Earnings: What's in the Offing?
Quidel (QDEL) delivered earnings and revenue surprises of 49.08% and 0.29%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?
Analysts Estimate Quidel (QDEL) to Report a Decline in Earnings: What to Look Out for
Quidel's (QDEL) fourth-quarter results are likely to reflect continued strength across its SARS-related products.
Neptune Wellness (NEPT) Reports Q3 Loss, Tops Revenue Estimates
Quidel (QDEL) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
How long are futures trading delayed?
Neptune Wellness (NEPT) delivered earnings and revenue surprises of -50% and 7.29%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?
How to calculate restricted stock?
Commodities & Futures: Futures prices are delayed at least 10 minutes as per exchange requirements. Change value during the period between open outcry settle and the commencement of the next day's trading is calculated as the difference between the last trade and the prior day's settle.
How to calculate P/E?
To calculate, start with total shares outstanding and subtract the number of restricted shares. Restricted stock typically is that issued to company insiders with limits on when it may be traded. A company's dividend expressed as a percentage of its current stock price.
About QDEL
The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations for the trailing 12 month period.
Analyst Forecast
Quidel Corporation develops, manufactures, and markets diagnostic testing solutions for applications in infectious diseases, cardiology, thyroid, women's and general health, eye health, gastrointestinal diseases, and toxicology worldwide.
News
According to 10 analysts, the average rating for QDEL stock is "Buy." The 12-month stock price forecast is 174.76, which is an increase of 66.84% from the latest price.
